These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6040790)

  • 21. [The function of naturally fibrinolysis inhibiting agents in normal plasma and normal thrombocytes].
    den Ottolander GJ; Leijnse B; Cremer-Elferink MM
    Ned Tijdschr Geneeskd; 1968 May; 112(19):920-1. PubMed ID: 4233299
    [No Abstract]   [Full Text] [Related]  

  • 22. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The antifibrinolytic activity of the blood in patients with cardiovascular pathologies under the effect of anticoagulant therapy].
    Urbaniuk KG; Andreenko GV; Mizin II
    Vrach Delo; 1967 Aug; 8():24-6. PubMed ID: 5612693
    [No Abstract]   [Full Text] [Related]  

  • 24. [Regulation of fibrinolysis and anti-fibrinolytic activity of the serum in children].
    Alekseenko IF
    Sov Zdravookhr Kirg; 1969; 6():18-22. PubMed ID: 5375017
    [No Abstract]   [Full Text] [Related]  

  • 25. Thrombotic disorders with increased levels of antiplasmin and antiplasminogen.
    NAEYE RL
    N Engl J Med; 1961 Nov; 265():867-71. PubMed ID: 14477844
    [No Abstract]   [Full Text] [Related]  

  • 26. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
    Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observations on fibrinolysis; plasminogen, plasmin, and antiplasmin content of human blood.
    MACFARLANE RG; PILLING J
    Lancet; 1946 Oct; 2(6425):562-5. PubMed ID: 21001709
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"].
    Daver J; Albugues MJ; du Pasquier JP; Ricoeur M
    Pathol Biol (Paris); 1970; 18(11):687-94. PubMed ID: 4247466
    [No Abstract]   [Full Text] [Related]  

  • 29. [Research on the pathogenetic mechanisms of hemorrhages due to induced venous stasis. II. Role of fibrinolysis in the pathogenesis of the hemorrhagic phenomenon due to stasis].
    Neri Serneri GG; Rossi Ferrini PL; Franchi F; Paoletti P
    Haematologica; 1965; 50(4):251-66. PubMed ID: 4953556
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in blood coagulation and fibrinolysis in the nephrotic syndrome.
    Thomson C; Forbes CD; Prentice CR; Kennedy AC
    Q J Med; 1974 Jul; 43(171):399-407. PubMed ID: 4547474
    [No Abstract]   [Full Text] [Related]  

  • 31. Coagulation/fibrinolysis disorder in patients with severe preeclampsia.
    Kobayashi T; Tokunaga N; Sugimura M; Suzuki K; Kanayama N; Nishiguchi T; Terao T
    Semin Thromb Hemost; 1999; 25(5):451-4. PubMed ID: 10625201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of age, sex, and diurnal variation on the human fibrinolystic system.
    Mann RD
    J Clin Pathol; 1967 May; 20(3):223-6. PubMed ID: 5602552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased fibrin/fibrinogen degradation products without increase of plasmin-alpha 2-plasmin inhibitor complex after hepatectomy for hepatocellular carcinoma.
    Takeda S; Katoh H; Takaki A; Okamoto K; Ohsato K
    Thromb Res; 1990 Jan; 57(2):289-300. PubMed ID: 2156347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research on the inhibitors of fibrinolysis: the methods of measuring antistreptokinase, antiplasmin and antitrypsin].
    GIACOMAZZI G
    Haematol Lat; 1961; 4():255-71. PubMed ID: 13898268
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasmin-a2-plasmin inhibitor complex in plasma of patients with thromboembolic diseases.
    Wada K; Takahashi H; Tatewaki W; Takizawa S; Shibata A
    Thromb Res; 1989 Dec; 56(6):661-5. PubMed ID: 2534445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin-antithrombin complex levels in subarachnoid hemorrhage.
    Fujii Y
    J Neurosurg; 1998 Mar; 88(3):614-5. PubMed ID: 9488325
    [No Abstract]   [Full Text] [Related]  

  • 37. [Coagulation and fibrinolysis proteins in nephrotic syndromes in children].
    Loirat C; Pillion G; Schlegel N; Douenias R; Mathieu H
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LVI-LXIII. PubMed ID: 539878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative clinical-pharmacological studies on synthetic antifibrinolytic agents].
    Markwardt F; Klöcking HP; Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):78-83. PubMed ID: 4189376
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the determination of antifibrinolysin (antiplasmin) activity in the blood].
    Kotovshchikova MA; Pleshakov VT
    Lab Delo; 1968; 12():715-7. PubMed ID: 4185066
    [No Abstract]   [Full Text] [Related]  

  • 40. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.
    Kalweit GA; Feindt P; Micek M; Gams E; Hellstern P
    Thromb Res; 2000 Feb; 97(3):105-11. PubMed ID: 10680641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.